ProSciento is the leading clinical research organization focused on the continuum of metabolic diseases. Building on 20 years of experience and more than 425 metabolic clinical trials conducted, ProSciento provides customized clinical research services for multinational clinical trial programs designed to give our clients an advantage in today’s rapidly evolving landscape of metabolic drug and device development. For more information, please visit www.prosciento.com Email: bd@prosciento.com